Wachtell Guides AbbVie In $21B Pharmacyclics Buy
Drugmaker AbbVie Inc. will pay $21 billion for Pharmacyclics Inc., the company announced Wednesday, a pickup that gives AbbVie, guided by Wachtell Lipton Rosen & Katz, access to one of the...To view the full article, register now.
Already a subscriber? Click here to view full article